LIGHTBEAM-U01 Master Protocol: A Phase 1/2 Platform Study to Evaluate the Safety and Efficacy of Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors

Brief Summary

Type:
Other

Study Type:
Screening

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT06395090

Study #:
CMH - MK9999-U01

Start Date:
Nov 11, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06395090

View Complete Trial Details & Eligibility at ClinicalTrials.gov